Cost-Effectiveness of Saxagliptin Compared With Glibenclamide as a Second-Line Therapy Added to Metformin for Type 2 Diabetes Mellitus in Ethiopia

Background. Metformin is a widely accepted first-line pharmacotherapy for patients with type 2 diabetes mellitus (T2DM). Treatment of T2DM with glibenclamide, saxagliptin, or one of the other second-line treatment agents is recommended when the first-line treatment (metformin) cannot control the dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Bekele, Mengistu, Norheim, Ole Frithjof, Hailu, Alemayehu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111283/
https://www.ncbi.nlm.nih.gov/pubmed/34104781
http://dx.doi.org/10.1177/23814683211005771

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111283/
https://www.ncbi.nlm.nih.gov/pubmed/34104781
http://dx.doi.org/10.1177/23814683211005771

Ejemplares similares